Genetic testing company Harmonyx recently launched the Harmonyx Test for Pain, a $99 assay designed to provide personalized guidance to patients taking medicine for chronic or acute pain. The test uses a patient swab taken at a Harmonyx partner pharmacy, and examines the effects of eight genes on a patient's metabolism and efficacy of more than 20 pain mediciations, ranging from common over-the-counter drugs like ibuprofen and naproxen to frequently prescribed medications like morphine, methadone, hydrocodone, codeine, and oxycodone. Harmonyx provides a state-licensed physician to review each patient test request, and, if deemed medically appropriate, the test is ordered on behalf of the patient. Detailed results are returned to the pharmacist and treating physician in as little as 24 hours after the lab receives the test, Harmonyx said. Harmonyx, based in Memphis, Tennessee, is CAP accredited and CLIA certified.